Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 2 (2006), Issue 10 (October)

1. Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.
   Aliment Pharmacol Ther, 24(8): 1223-30. [Abstract] [Full-text]
2. Immunological and virological aspects of autologous stem cell transplantation in HIV+ patients.
   Microbes Infect, 8(9): 2563-8. [Abstract] [Full-text]
3. Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C.
   Liver Int, 26(9): 1100-10. [Abstract] [Full-text]
4. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study.
   Comp Hepatol, 5: 4. [Abstract] [Full-text]
5. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.
   J Infect Dis, 194(9): 1309-18. [Abstract] [Full-text]
6. Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.
   J Virol, 80(21): 10794-801. [Abstract] [Full-text]
7. Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France.
   Eur J Epidemiol, 21(8): 615-618. [Abstract] [Full-text]
8. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
   AIDS, 20(16): 2099-106. [Abstract] [Full-text]
9. Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.
   J Antimicrob Chemother, 58(5): 1017-23. [Abstract] [Full-text]
10. Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: A preliminary study.
    Hepatol Res, 36(3): 167-75. [Abstract] [Full-text]
11. A Cohort Study of the Food Effect on Virological Failure and Treatment Discontinuation in Patients on HAART Containing Didanosine Enteric-Coated Capsules (FOODDIe Study).
    HIV Clin Trials, 7(4): 155-62. [Abstract] [Full-text]
12. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.
    Diabetes Care, 29(11): 2462-6. [Abstract] [Full-text]
13. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
    Cancer, 107(9): 2282-90. [Abstract] [Full-text]
14. Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.
    J Med Virol, 78(12): 1537-41. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.